Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0000899243-21-030722

Director sold 3,153,138 shares at an average $4.61 ($14,546,264)

  • Director acquired 852,500 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ARMISTICE CAPITAL, LLC Director 2021-07-27 Conversion +852,500 $4.80 $4,092,000 4,199,101 I
ARMISTICE CAPITAL, LLC Director 2021-07-27 Sale −73,101 $7.06 $516,108 4,126,000 I
ARMISTICE CAPITAL, LLC Director 2021-07-27 Sale −461,797 $6.45 $2,980,853 3,664,203 I
ARMISTICE CAPITAL, LLC Director 2021-07-27 Sale −729,114 $5.44 $3,966,161 2,935,089 I
ARMISTICE CAPITAL, LLC Director 2021-07-27 Sale −532,069 $4.59 $2,440,973 2,403,020 I
ARMISTICE CAPITAL, LLC Director 2021-07-27 Sale −581,614 $3.80 $2,209,552 1,821,406 I
ARMISTICE CAPITAL, LLC Director 2021-07-28 Sale −375,443 $3.28 $1,232,617 1,445,963 I
ARMISTICE CAPITAL, LLC Director 2021-07-29 Sale −400,000 $3.00 $1,200,000 1,045,963 I
Derivatives
ARMISTICE CAPITAL, LLC Director 2021-07-27 Conversion · Series C Convertible Preferred Stock −4,092 0 I
Open-market sales · 3,153,138 sh · avg $4.61 · $14,546,264
Loading xslF345X03/doc4.xml…